MetaCap

Cullinan Therapeutics (CGEM) News

NASDAQ: CGEMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

8.89-0.18 (-1.98%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

CGEM news summary

We found 12 recent headlines mentioning Cullinan Therapeutics (CGEM): 0 in the past week and 12 in the past 30 days, most often from GlobeNewswire, Nasdaq, Seeking Alpha. For price context, CGEM is down 1.98% at $8.89. The most recent story, "Cullinan Partner Taiho Completes FDA Filing For Zipalertinib Combo In First-Line Lung Cancer", was published by Nasdaq on Nov 13, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest Cullinan Therapeutics headlines

Stocks mentioned alongside CGEM

Compare CGEM